Artisan Partners Limited Partnership Ascendis Pharma A/S Transaction History
Artisan Partners Limited Partnership
- $63.1 Billion
- Q2 2024
A detailed history of Artisan Partners Limited Partnership transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 4,295,029 shares of ASND stock, worth $544 Million. This represents 0.93% of its overall portfolio holdings.
Number of Shares
4,295,029
Previous 5,671,934
24.28%
Holding current value
$544 Million
Previous $857 Million
31.68%
% of portfolio
0.93%
Previous 1.32%
Shares
25 transactions
Others Institutions Holding ASND
# of Institutions
225Shares Held
56.6MCall Options Held
142KPut Options Held
259K-
Ra Capital Management, L.P. Boston, MA10.1MShares$1.28 Billion20.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.96MShares$628 Million3.41% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.2MShares$531 Million7.81% of portfolio
-
Janus Henderson Group PLC London, X03.92MShares$496 Million0.29% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$331 Million0.06% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.07B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...